PAII

Business Context and Reporting Period

Company: Pyrophyte Acquisition Corp. II (PAII)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: May 1, 2025 (Inception) through June 30, 2025
Business Status: A Cayman Islands exempted company formed as a "blank check" SPAC. The company has not commenced operations or generated revenue. Its sole purpose is to effect a business combination with one or more target businesses, specifically targeting the energy sector (critical minerals, materials, equipment, and technologies).

Key Financial Metrics

Note: The financial statements reflect the pre-IPO period. The Initial Public Offering (IPO) was consummated on July 18, 2025, subsequent to the reporting period.

Material Changes and Subsequent Events

The most significant material change occurred after the reporting period ended on June 30, 2025:

• Initial Public Offering (IPO): On July 18, 2025, the company consummated an IPO of 17,500,000 units at $10.00 per unit, generating gross proceeds of $175,000,000.
• Over-Allotment Exercise: On July 24, 2025, underwriters partially exercised their over-allotment option, purchasing an additional 2,541,150 units for $25,411,500. The remaining 83,850 units were forfeited.
• Total Gross Proceeds: Combined IPO and over-allotment proceeds totaled $200,411,500.
• Trust Account: Approximately $200,411,500 ($10.00 per unit) was deposited into a U.S.-based Trust Account.
• Private Placement: Simultaneously with the IPO, the company sold 5,050,000 private placement warrants to the Sponsor for $5,050,000.
• Transaction Costs: Total transaction costs were approximately $12.8 million, including $9.4 million in deferred underwriting fees.

Outlook, Risks, and Management Commentary

Outlook and Strategy: The company intends to use proceeds from the IPO and private placement to acquire a target business in the energy sector. It has 24 months from the closing of the IPO (July 18, 2025) to complete a business combination. If unsuccessful, the company will liquidate and redeem public shares from the Trust Account.

Risks and Contingencies:

• Going Concern: As of June 30, 2025, the company had no cash. Liquidity is now dependent on the IPO proceeds held in the Trust Account and outside the Trust Account for working capital.
• Market Conditions: Risks include potential adverse effects from U.S. trade policies, tariffs, and global economic instability which could impact target companies.
• Redemption Risk: Public shareholders have the right to redeem their shares for cash upon the completion of a business combination, which could reduce the funds available for the transaction.
• Warrant Liability: Warrants are classified as equity; however, failure to maintain an effective registration statement could force cashless exercise.

Unusual Items: The company incurred $102,000 in general and administrative expenses during the pre-IPO period, funded by a related-party promissory note and the issuance of founder shares. No share-based compensation expense was recognized for shares granted to directors as the performance condition (business combination) was not deemed probable as of June 30, 2025.

Investor Verification Checklist

• Trust Account Balance: Verify the exact amount deposited in the Trust Account ($200,411,500) and the interest-bearing status of the funds.
• Deferred Underwriting Fees: Confirm the $9,399,690 deferred fee obligation payable only upon successful business combination.
• Share Count and Dilution: Verify the final number of Class A shares outstanding post-IPO and the conversion ratio of Class B founder shares (targeting 26.5% ownership post-combination).
• Redemption Rights: Review the specific terms regarding shareholder redemption rights and the 24-month deadline for a business combination.
• Related Party Transactions: Confirm the terms of the administrative support agreement ($35,000/month) and the settlement of the $75,000 promissory note via warrant issuance.